Hookworm vaccine
1 Assignment
0 Petitions
Accused Products
Abstract
Preparations which elicit an immune response to hookworm antigens and which may be utilized as hookworm vaccines are provided. In addition, a method of increasing the effectiveness of vaccinations against infectious diseases in patients infected with hookworm is provided. The method involves chemically treating the hookworm infestation prior to administering the vaccine.
31 Citations
132 Claims
-
1-33. -33. (cancelled):
-
34. A method for enabling vaccination of a patient against infectious diseases, comprising the steps of:
-
a) treating hookworm infection to a degree sufficient to increase lymphocyte proliferation; and
b) vaccinating said patient against said infectious disease. - View Dependent Claims (35)
-
-
36. A method for enabling hookworm vaccination, comprising the steps of:
-
a) chemically treating a hookworm infected patient to ameliorate hookworm infection; and
b) vaccinating said patient with a recombinant or synthetic antigen or fragment thereof derived from hookworm after amelioration of hookworm infection.
-
-
37-97. -97. (Cancelled)
-
98. A composition comprising:
-
a cocktail of recombinant or synthetic antigens derived from hookworm, and, a pharmacologically acceptable carrier. - View Dependent Claims (99, 100, 101, 102)
-
-
103. A method of vaccinating or eliciting an immune response to hookworm in a mammal, comprising the step of,
administering to said mammal an effective amount of a composition comprising a recombinant or synthetic antigen derived from hookworm, and a pharmacologically acceptable carrier.
-
110. A method of reducing blood loss in a patient infected with hookworm, comprising the step of
administering to said patient an effective amount of a composition comprising a recombinant or synthetic antigen derived from hookworm, and a pharmacologically acceptable carrier.
-
117. A method of reducing hookworm size, or quantitative egg count or hookworm burden in a patient infected with hookworm, comprising the step of administering to said mammal an effective amount of a composition comprising
a recombinant or synthetic antigen derived from hookworm, and a pharmacologically acceptable carrier.
-
124. A method of decreasing L3 migration across skin of a mammal, comprising the step of
administering to said mammal an effective amount of a composition comprising a recombinant or synthetic antigen derived from hookworm, and a pharmacologically acceptable carrier.
-
131. A nucleotide sequence represented by SEQ ID NO:
- 76.
-
132. An amino acid sequence represented by SEQ ID NO:
- 77.
Specification